Update from Better Choice Company Chairman
As the healthcare landscape evolves, highlighting transformative opportunities becomes essential. Better Choice Company, a frontrunner in the pet health and wellness sector, is making strides towards finalizing its acquisition of SRx Health Solutions Inc. This letter, penned by Chairman Michael Young, addresses shareholders’ inquiries and insights about this pivotal moment in the company’s ongoing journey.
Strategic Vision for Growth
Envisioning a robust future, the collaboration between Better Choice and SRx Health aims to establish a standout presence in the global health and wellness market. The projected financial outcomes for the consolidated entities are expected to be remarkable, estimating revenues around $270 million and EBITDA exceeding $10 million by 2025. This acquisition is designed not only to deliver better health solutions for families and pets but also to boost efficiency and streamline operations between the two companies.
Significance of the Acquisition
The acquisition presents an opportunity to create a powerhouse in the pet health sector. Better Choice has consistently demonstrated remarkable growth, particularly with its brand Halo, which secured impressive sales in the past year. Meanwhile, SRx Health, known for its extensive specialty pharmacy network in Canada, has reported substantial revenue growth, making them an ideal partner. The strategic union allows both companies to leverage each other’s strengths, promising enhanced product offerings and customer experiences.
Operational Efficiency and Market Expansion
Combining strengths from both companies opens the door to immediate operational efficiencies and cost-saving measures. Initial forecasts predict annual savings of about $1.7 million. This merger does not only focus on cost savings but emphasizes expansion into new markets. The businesses aim to explore untapped regions including the United States, Europe, and Asia-Pacific. Such expansions are vital in a market driven by pet humanization trends.
New Ventures in Veterinary Medicine
One of the exciting developments anticipated from this merger is the foray into veterinary medicine planned for 2025 through a venture named Better Pet Rx. With the expertise of SRx Health's leadership and established connections in the pharmaceutical realm, this initiative is poised to enrich the Halo portfolio and cater to an expanding market.
Shareholder Engagement and Support
As the anticipated closing for this transaction approaches, shareholder engagement is paramount. The management teams encourage shareholder involvement to ensure a smooth transition and propel both companies into a prosperous future. The integrated vision is not only to solidify leadership in the market but also to embrace innovation and customer needs effectively, providing unparalleled services and products. Michael Young expresses sincere gratitude towards shareholders for their steadfast support throughout this transformative journey.
About Better Choice Company
Better Choice Company specializes in producing high-quality, nutritious pet food, aiming for an industry shift towards healthier options for pets. Its holistic approach focuses on improving the lives of dogs and cats, capitalizing on the increasing trend of pet humanization. Through its established digital channels and commitment to pet wellness, Better Choice prioritizes education to ensure pet owners make informed decisions regarding their pets' health.
About SRx Health
Fast emerging as a leader in the specialty pharmacy segment, SRx Health is dedicated to managing complex healthcare journeys. The company combines its extensive pharmacy networks and infusion clinics to significantly enhance healthcare delivery across Canada, with aspirations to expand globally. Their focus on chronic disease management and patient-centered services cements SRx Health's reputation as a key player in the healthcare provider landscape.
Frequently Asked Questions
What is the expected outcome of the acquisition?
The strategic merger is anticipated to generate substantial revenue growth and operational efficiencies, aiming for $270 million in revenue by 2025.
How will Better Choice enhance its product offerings?
By expanding into veterinary medicine and combining resources with SRx Health, Better Choice aims to broaden the Halo product line and improve health solutions for pets.
What cost savings are projected from the merger?
Initial forecasts estimate annual cost savings of approximately $1.7 million, set to increase as integration progresses.
What regions will Better Choice expand into?
The merger plans for expansion into markets like the United States, European Union, and Asia-Pacific, tapping into new growth opportunities.
Who should shareholders contact for more information?
Shareholders may contact Kent Cunningham, CEO of Better Choice Company, for further insights regarding the acquisition and business plans.
